FrieslandCampina Ingredients extended its Vana-Sana range of micro-encapsulated long-chain polyunsaturated fatty acid (LCPUFA) ingredients for infant milk formula (IMF) with three new fish-oil-free launches.
FrieslandCampina Ingredients extended its Vana-Sana range of micro-encapsulated long-chain polyunsaturated fatty acid (LCPUFA) ingredients for infant milk formula (IMF) with three new fish-oil-free launches: two new docosahexaenoic acid (DHA) products based on algae oil—Vana-Sana DHA algae 20L and Vana-Sana DHA algae 11N—and one arachidonic acid (ARA) derived from fungi oil: Vana-Sana ARA 20L.
The new products fit the bill for a clean label due to the elimination of dipotassium phosphate (a buffering agent) and silicon dioxide (a flow agent). They offer easier storage and handling, and improved stability and longer shelf life, even at ambient temperatures.
“When it comes to choosing the right ingredients to add to infant milk formula, DHA and ARA are understandably at the top of the list for their important health benefits. But they can be difficult to formulate while preserving their sensory and nutritional profile,” said MarischaNikkels, marketing manager at FrieslandCampina Ingredients, in a press release. “Now with the launch of these latest DHA and ARA ingredients, manufacturers can fortify their products with an even higher concentration of LCPUFAs and ensure more sustainable on-pack credentials. Micro-encapsulation is also win-win for consumers – with no off-tastes or bad odors, parents can have the peace of mind that they’re providing one of the best infant milk formulas for their babies.”
The ne range features high oil loads: 20 g of DHA in Vana-Sana DHA algae 20L and 20 g of ARA in Vana®-Sana ARA 20L per 100g of powder. Both ingredients are also encapsulated in a lactose-powder matrix instead of a glucose one.
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.